12/19
11:05 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
Low
Report
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
12/19
10:00 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock.
12/19
10:00 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $1.00 price target on the stock.
12/19
09:26 am
howl
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
Medium
Report
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
12/19
09:26 am
howl
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
Medium
Report
Werewolf Therapeutics downgraded to Neutral from Outperform at Wedbush
12/19
07:19 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/12
08:05 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..